Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Congressional Testimony

Congressional Testimony

                        Congressional Testimony 2018 - 2019
          Congressional Testimony  2017
          Congressional Testimony 2016 Home
          News & Events
          Congressional Testimony
          Congressional Testimony  2017Congressional Testimony Congressional Testimony  2017
  
  	
    Share
    Post
    Linkedin

    Email
    PrintThis section includes testimony by FDA officials before House and Senate Committees and Subcommittees.

December 2017

12/07/2017: Implementation of the 21st Century Cures Act: Progress and the Path Forward for Medical Innovation
	Scott Gottlieb, M.D. before the Committee on Health, Education, Labor & PensionsNovember 2017

11/30/2017: Implementing the 21st Century Cures Act: An Update From FDA and NIH
	Scott Gottlieb, M.D. before the Subcommittee on Health, House Energy and Commerce CommitteeOctober 2017

10/25/2018: Federal Efforts to Combat the Opioid Crisis: A Status Update on CARA and Other Initiatives
	Written testimony on behalf of Elinore McCance-Katz, M.D., Ph.D., SAMHSA; Anne Schuchat, M.D., CDC; Nora Volkow, M.D., NIH, and Scott Gottlieb, M.D., FDA before the House Committee on Energy and Commerce
	10/24/2017: Examining HHS' Public Health Preparedness for and Response to the 2017 Hurricane Season 
	Scott Gottlieb, M.D., before the Subcommittee on Oversight and Investigations, House Committee on Energy and Commerce
	10/11/2017: Evaluating the Paperwork Reduction Act Part II: Are Burdens Being Reduced? 
	Todd Simpson before the House Committee on Small Business
	10/05/2017: The Federal Response to the Opioid Crisis 
	Written testimony on behalf of: Elinore McCance-Katz, M.D., Ph.D., SAMHSA; Deborah Houry, M.D., MPH, CDC; Francis Collins, M.D., Ph.D., NIH; and Scott Gottlieb, M.D., FDA; before the Senate Health, Education, Labor and Pensions (HELP) Committee
	10/03/2017: Examining Patient Access to Investigational Drugs 
	Statement of Scott Gottlieb, M.D., before the House Subcommittee on Health, Committee on Energy and CommerceSeptember 2017

09/13/2017: Modernizing FDA's Regulation of Over-the-Counter Drugs 
	Janet Woodcock, M.D., before the House Energy and Commerce Committee, Subcommittee on HealthJuly 2017

07/27/2017: Antitrust Concerns and The FDA Approval Process 
	Scott Gottlieb, M.D., before the House Committee on the Judiciary, Subcommittee on Regulatory Reform, Commercial and Antitrust LawJune 2017

06/20/2017: President's Fiscal Year 2018 Budget Request (Senate) 
	Scott Gottlieb, M.D., before the Senate Committee on Appropriations, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related AgenciesMay 2017

05/25/2017: The President's Fiscal Year 2018 Budget Request for FDA 
	Scott Gottlieb, M.D., before the House Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
	05/23/2017: U.S. Public Health Response to the Zika Virus: Continuing Challenges 
	Luciana Borio, M.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
	05/02//2017: Examining Improvements to the Regulation of Medical Technologies 
	Jeffrey Shuren, M.D., J.D., before the House Committee on Energy and Commerce, Subcommittee on HealthMarch 2017

03/28/2017: Examining FDA's Medical Device User Fee Program 
	Jeffrey Shuren, M.D., J.D. before the Committee on Energy and Commerce Subcommittee on Health, United States House of Representatives
	03/21/2017: Prescription Drug User Fee Act Reauthorization (PDUFA VI), Medical Device User Fee Act Reauthorization (MDUFA IV), Generic Drug User Fee Act Reauthorization (GDUFA II), and Biosimilar User Fee Act Reauthorization (BsUFA II) 
	Janet Woodcock, M.D., Peter Marks, M.D., Ph.D., and Jeffrey Shuren, M.D., J.D., before the Committee on Health, Education, Labor and Pensions, U.S. Senate
	03/02/2017: Generic Drug User Fee Act Reauthorization (GDUFA II), Biosimilar User Fee Act Reauthorization (BsUFA II) 
	Janet Woodcock, M.D. before the Committee on Energy and Commerce Subcommittee on Health, United States House of Representatives

                                                                                  Content current as of:
      01/26/2018Congressional Testimony

          
                        Congressional Testimony 2018 - 2019
          Congressional Testimony  2017
          Congressional Testimony 2016
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop